Outcomes of Different Thyroid Resections for Multinodular Non-toxic Goiter

Sponsor
Jagiellonian University (Other)
Overall Status
Completed
CT.gov ID
NCT00946894
Collaborator
(none)
600
1
3
107
5.6

Study Details

Study Description

Brief Summary

The aim of this three-arm randomized study was to evaluate results of different thyroid resection modes among patients with bilateral multinodular non-toxic goiter, with special emphasis put on recurrence rate and morbidity rate, in a 5-year follow-up.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Total thyroidectomy
  • Procedure: Dunhill operation
  • Procedure: Bilateral subtotal thyroidectomy
N/A

Detailed Description

The extent of thyroid resection in bilateral multinodular non-toxic goiter remains controversial. Surgeons still continue to debate whether the potential benefits of total thyroidectomy outweigh the potential complications. Most low-volume surgeons avoid to perform total thyroidectomy owing to the possible complications such as permanent recurrent laryngeal nerve palsy and permanent hypoparathyroidism. On the other hand, the increasing number of total thyroidectomies are currently performed in high-volume endocrine surgery units, and the indication for this procedure include thyroid cancer, Graves disease and multinodular goiter. Recently there has been increasing acceptance for performing total thyroidectomy for bilateral multinodular non-toxic goiter as it removes the disease process completely, lowers local recurrence rate and avoids the substantial risk of reoperative surgery, and involves only a minimal risk of morbidity. This common perception is based largely on single-institution retrospective data, a few multi-institutional retrospective experiences, and only a few prospective randomized studies comparing the outcomes of total vs. subtotal thyroidectomy.

Study Design

Study Type:
Interventional
Actual Enrollment :
600 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Participant)
Primary Purpose:
Treatment
Official Title:
Five-year Follow up of a Randomized Clinical Trial of Total Thyroidectomy Versus Dunhill Operation Versus Bilateral Subtotal Thyroidectomy for Multinodular Non-toxic Goiter.
Study Start Date :
Jan 1, 2000
Actual Primary Completion Date :
Dec 1, 2003
Actual Study Completion Date :
Dec 1, 2008

Arms and Interventions

Arm Intervention/Treatment
Experimental: Total thyroidectomy

Patients who underwent total thyroidectomy

Procedure: Total thyroidectomy
Total thyroidectomy
Other Names:
  • TT
  • Experimental: Dunhill operation

    Patients who underwent unilateral total thyroid lobectomy and contralateral subtotal thyroid lobectomy

    Procedure: Dunhill operation
    Unilateral total thyroid lobectomy and contralateral subtotal thyroid lobectomy
    Other Names:
  • DO
  • Active Comparator: Bilateral subtotal thyroidectomy

    Patients who underwent bilateral subtotal thyroidectomy

    Procedure: Bilateral subtotal thyroidectomy
    Bilateral subtotal thyroidectomy
    Other Names:
  • BST
  • Outcome Measures

    Primary Outcome Measures

    1. Primary outcome measure was prevalence of recurrent goiter and need for redo surgery. [at 12, 24, 36, 48 and 60 months after surgery]

    Secondary Outcome Measures

    1. Secondary outcome measure was postoperative morbidity rate (hypoparathyroidism and recurrent laryngeal nerve injury). [at 3, 6, 9, 12, 24, 36, 48 and 60 months after surgery]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 65 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No

    Inclusion Criterion

    • a bilateral non-toxic multinodular goiter with normal appearing on ultrasound of the neck posterior aspects of both thyroid lobes.
    Exclusion Criteria:
    • multinodular goiter involving posterior aspect/s of thyroid lobe/s,

    • suspicion of thyroid cancer,

    • previous thyroid surgery,

    • thyroiditis,

    • subclinical or clinically overt hypothyroidism or hyperthyroidism,

    • pregnancy or lactation,

    • age < 18 years or > 65 years,

    • ASA 4 grade (American Society of Anesthesiology),

    • inability to comply with the follow-up protocol.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Jagiellonian University, College of Medicine, Department of Endocrine Surgery, 3rd Chair of General Surgery Krakow Poland 31-202

    Sponsors and Collaborators

    • Jagiellonian University

    Investigators

    • Principal Investigator: Marcin Barczynski, MD, PhD, Jagiellonian University College of Medicine

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    , ,
    ClinicalTrials.gov Identifier:
    NCT00946894
    Other Study ID Numbers:
    • BBN/501/ZKL/68/L
    First Posted:
    Jul 27, 2009
    Last Update Posted:
    Jul 27, 2009
    Last Verified:
    Jul 1, 2009

    Study Results

    No Results Posted as of Jul 27, 2009